Vanguard Personalized Indexing Management, LLC Allogene Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.46 Billion
- Q4 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 20,513 shares of ALLO stock, worth $53,333. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,513
Previous 15,797
29.85%
Holding current value
$53,333
Previous $44,000
2.27%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ALLO
# of Institutions
176Shares Held
139MCall Options Held
75.8KPut Options Held
52.8K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$48.7 Million1.1% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$42.8 Million0.0% of portfolio
-
Lynx1 Capital Management LP San Juan, PR10.9MShares$28.3 Million9.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8MShares$20.8 Million0.0% of portfolio
-
State Street Corp Boston, MA7.25MShares$18.8 Million0.0% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $374M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...